Literature DB >> 20631575

Concordance between measures of functioning, symptoms, and change: examining the GAF, CGI-S, CGI-C, and PANSS.

Jonathan Rabinowitz, Stephen Levine, Guadalupe Martinez.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20631575     DOI: 10.1097/JCP.0b013e3181e7145f

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN: 0271-0749            Impact factor:   3.153


× No keyword cloud information.
  5 in total

1.  The association of psychopathology with concurrent level of functioning and subjective well-being in persons with schizophrenia spectrum disorders.

Authors:  Lisa Hochstrasser; Stefan Borgwardt; Martin Lambert; Benno G Schimmelmann; Undine E Lang; Rolf-Dieter Stieglitz; Christian G Huber
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2017-03-29       Impact factor: 5.270

2.  The Impact of Long-acting Paliperidone in Reducing Hospitalizations and Clinical Severity in Recent Onset Schizophrenia: A Mirror-image Study in Real-world Clinical Setting.

Authors:  Vjekoslav Peitl; Branka Aukst Margetić; Branka Vidrih; Dalibor Karlović
Journal:  Clin Psychopharmacol Neurosci       Date:  2022-02-28       Impact factor: 2.582

3.  A structured interview guide for global impressions: increasing reliability and scoring accuracy for CNS trials.

Authors:  Steven D Targum; Celine Houser; Joanne Northcutt; Jessica A Little; Andrew J Cutler; David P Walling
Journal:  Ann Gen Psychiatry       Date:  2013-01-31       Impact factor: 3.455

4.  Adaptation of the Clinical Global Impression for Use in Correctional Settings: The CGI-C.

Authors:  Roland M Jones; Kiran Patel; Mario Moscovici; Robert McMaster; Graham Glancy; Alexander I F Simpson
Journal:  Front Psychiatry       Date:  2019-09-18       Impact factor: 4.157

5.  Validation of the Clinical Global Impression-Corrections Scale (CGI-C) by Equipercentile Linking to the BPRS-E.

Authors:  Roland M Jones; Cory Gerritsen; Margaret Maheandiran; Alexander I F Simpson
Journal:  Front Psychiatry       Date:  2020-03-20       Impact factor: 4.157

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.